|
MED23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.811000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.345400E-01 |
| Normal-vs-Stage2 |
2.010800E-01 |
| Normal-vs-Stage3 |
7.900400E-01 |
| Normal-vs-Stage4 |
4.564000E-01 |
| Stage1-vs-Stage2 |
2.097800E-01 |
| Stage1-vs-Stage3 |
6.658600E-01 |
| Stage1-vs-Stage4 |
4.688600E-01 |
| Stage2-vs-Stage3 |
1.630420E-01 |
| Stage2-vs-Stage4 |
8.680800E-01 |
| Stage3-vs-Stage4 |
3.283000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.924200E-01 |
| Normal-vs-AfricanAmerican |
2.661000E-01 |
| Normal-vs-Asian |
2.140600E-01 |
| Caucasian-vs-AfricanAmerican |
5.649800E-01 |
| Caucasian-vs-Asian |
1.213830E-02 |
| AfricanAmerican-vs-Asian |
1.367820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.661600E-01 |
| Normal-vs-Female |
1.879450E-01 |
| Male-vs-Female |
3.770400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.482600E-01 |
| Normal-vs-Extreme_Weight |
3.728200E-01 |
| Normal-vs-Obese |
2.260000E-01 |
| Normal-vs-Extreme_Obese |
6.720200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.550180E-01 |
| Normal_Weight-vs-Obese |
7.798000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.641200E-01 |
| Extreme_Weight-vs-Obese |
5.857700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.932800E-01 |
| Obese-vs-Extreme_Obese |
7.337200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.705000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.970000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.495800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.111210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.718000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.935800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.651800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.524200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978040E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.710200E-02 |
| Normal-VS-Type2 PRCC |
2.395600E-01 |
| Normal-VS-KIRP CIMP |
6.481000E-01 |
| Normal-VS-Unclassified PRCC |
6.327800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.301000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.184800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.981200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.881200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.069400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.494200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.916160E-01 |
| Normal-vs-N1 |
2.399800E-01 |
| Normal-vs-N2 |
2.364100E-03 |
| N0-vs-N1 |
6.676400E-02 |
| N0-vs-N2 |
8.051800E-02 |
| N1-vs-N2 |
5.161500E-02 |
|
|
